over-exuberant inflammatory responseThe new drug candidate, FSD201, is being developed to address the "over-exuberant inflammatory response" characterized by Covid-19 infection. The inflammatory response may lead to a cytokine storm — where the body starts to attack its own cells and tissues, rather than just attacking a virus — and ultimately death.